Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wilko Weichert

Showing results (181-190 of 520) with videos related to

Pageof 52
Sort By:
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|February 23, 2011
Genome-wide gene expression profiling of formalin-fixed paraffin-embedded breast cancer core biopsies using microarraysJan Budczies, Wilko Weichert, Aurelia Noske, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 26, 2004
Expression of the ELAV-like protein HuR is associated with higher tumor grade and increased cyclooxygenase-2 expression in human breast carcinomaCarsten Denkert, Wilko Weichert, Klaus-Jürgen Winzer, et al.
Virchows Archiv : an International Journal of Pathology|March 24, 2005
Polo-like kinase isoforms in breast cancer: expression patterns and prognostic implicationsWilko Weichert, Glen Kristiansen, Klaus-Jürgen Winzer, et al.
Scandinavian Journal of Gastroenterology|June 28, 2008
Fungi and inflammatory bowel diseases: Alterations of composition and diversityStephan J Ott, Tanja Kühbacher, Meike Musfeldt, et al.
The Prostate|February 1, 2007
Overexpression of cyclooxygenase-2 in human prostate carcinoma and prostatic intraepithelial neoplasia-association with increased expression of Polo-like kinase-1Carsten Denkert, Andrea Thoma, Silvia Niesporek, et al.
BMC Cancer|May 1, 2013
Differential expression of histone deacetylases HDAC1, 2 and 3 in human breast cancer--overexpression of HDAC2 and HDAC3 is associated with clinicopathological indicators of disease progressionBerit Maria Müller, Lisa Jana, Atsuko Kasajima, et al.
Oncotarget|October 10, 2014
Mutational profiles in triple-negative breast cancer defined by ultradeep multigene sequencing show high rates of PI3K pathway alterations and clinically relevant entity subgroup specific differencesMark Kriegsmann, Volker Endris, Thomas Wolf, et al.
International Journal of Surgical Pathology|June 8, 2012
Unmasked: when a clinically malignant disease turns out infectious. A rare case of tularemiaOlcay Cem Bulut, Gerhard Dyckhoff, Wolf Splettstoesser, et al.
Genes, Chromosomes & Cancer|December 10, 2015
Genetic heterogeneity in synchronous colorectal cancers impacts genotyping approaches and therapeutic strategiesMoritz Jesinghaus, Nicole Pfarr, Matthias Kloor, et al.
Cancer Letters|April 6, 2006
Specific inhibition of AKT2 by RNA interference results in reduction of ovarian cancer cell proliferation: increased expression of AKT in advanced ovarian cancerAurelia Noske, Alexander Kaszubiak, Wilko Weichert, et al.
Pageof 52

Showing results (181-190 of 520) with videos related to

Sort By:
Pageof 52
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|February 23, 2011
Genome-wide gene expression profiling of formalin-fixed paraffin-embedded breast cancer core biopsies using microarraysJan Budczies, Wilko Weichert, Aurelia Noske, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 26, 2004
Expression of the ELAV-like protein HuR is associated with higher tumor grade and increased cyclooxygenase-2 expression in human breast carcinomaCarsten Denkert, Wilko Weichert, Klaus-Jürgen Winzer, et al.
Virchows Archiv : an International Journal of Pathology|March 24, 2005
Polo-like kinase isoforms in breast cancer: expression patterns and prognostic implicationsWilko Weichert, Glen Kristiansen, Klaus-Jürgen Winzer, et al.
Scandinavian Journal of Gastroenterology|June 28, 2008
Fungi and inflammatory bowel diseases: Alterations of composition and diversityStephan J Ott, Tanja Kühbacher, Meike Musfeldt, et al.
The Prostate|February 1, 2007
Overexpression of cyclooxygenase-2 in human prostate carcinoma and prostatic intraepithelial neoplasia-association with increased expression of Polo-like kinase-1Carsten Denkert, Andrea Thoma, Silvia Niesporek, et al.
BMC Cancer|May 1, 2013
Differential expression of histone deacetylases HDAC1, 2 and 3 in human breast cancer--overexpression of HDAC2 and HDAC3 is associated with clinicopathological indicators of disease progressionBerit Maria Müller, Lisa Jana, Atsuko Kasajima, et al.
Oncotarget|October 10, 2014
Mutational profiles in triple-negative breast cancer defined by ultradeep multigene sequencing show high rates of PI3K pathway alterations and clinically relevant entity subgroup specific differencesMark Kriegsmann, Volker Endris, Thomas Wolf, et al.
International Journal of Surgical Pathology|June 8, 2012
Unmasked: when a clinically malignant disease turns out infectious. A rare case of tularemiaOlcay Cem Bulut, Gerhard Dyckhoff, Wolf Splettstoesser, et al.
Genes, Chromosomes & Cancer|December 10, 2015
Genetic heterogeneity in synchronous colorectal cancers impacts genotyping approaches and therapeutic strategiesMoritz Jesinghaus, Nicole Pfarr, Matthias Kloor, et al.
Cancer Letters|April 6, 2006
Specific inhibition of AKT2 by RNA interference results in reduction of ovarian cancer cell proliferation: increased expression of AKT in advanced ovarian cancerAurelia Noske, Alexander Kaszubiak, Wilko Weichert, et al.
Pageof 52